GLP-1 drugs mimic a naturally occurring hormone called glucagon-like peptide-1, which plays a role in regulating blood sugar and appetite
Demand forecast and sales forecast for GLP-1 Diabetes Treatment Drugs Market in the USA GLP-1 diabetes treatment drugs market in the United States is projected to grow at a CAGR of 24.0% through 2035, supported by the country's advanced diabetes care sector, pharmaceutical innovation capabilities, and established leadership in healthcare solutions
The drug has risen to recognition thanks to one side effect: weight loss
Sadly, I have news for you: life is not so simple
Adding to the pressure on J&J is a September 2024 announcement from Cignas Evernorth Health Services that it will offer an interchangeable biosimilar alternative to Stelara at $0 out-of-pocket
What matters most is finding the medication that best fits your health goals, tolerability, and lifestyle